Research Paper Volume 14, Issue 15 pp 6358—6376
Clinical outcomes and potential therapies prediction of subgroups based on a ferroptosis-related long non-coding RNA signature for gastric cancer
Figure 5. GSEA and GSVA demonstrating the immune-related pathways enriched in the high-FRLSG group. (A–D) Immune-related pathways enriched in the high-FRLSG group through GSEA. (E) GSVA demonstrating the enriched pathways associated with FRLSG. Blue bars indicated the high-FRLSG group associated pathway, while green bars indicated the low-FRLSG group associated pathways.